Reporting in Accordance with the EU Taxonomy Regulation

Fundamentals

The EU taxonomy for sustainable activities (hereinafter “EU taxonomy”) is a classification system that translates the climate and environmental objectives of the European Union (EU) into criteria for sustainable economic activities. For this purpose, the EU taxonomy defines various key figures and qualitative information that the Group must disclose. The introduction of the disclosure obligation under Article 8 of Regulation (EU) 2020/852 of the European Parliament and of the European Council dated June 18, 2020, which establishes a framework to facilitate sustainable investment and amends Regulation (EU) 2019/2088 (hereinafter “EU Taxonomy Regulation”) and the Delegated Acts adopted in this regard, was carried out in several phases:

  • For the 2021 reporting year, key figures were initially stated only for what are known as taxonomy-eligible economic activities and were limited to those that make a substantial contribution to climate change mitigation or climate change adaptation, as defined by the EU Taxonomy Regulation. An economic activity is considered taxonomy-eligible if it falls within the regulatory scope of the EU taxonomy.
  • For the 2022 reporting year, in addition to the degree to which economic activities making a substantial contribution to climate change mitigation or climate change adaptation as defined by the EU Taxonomy Regulation are taxonomy-eligible, it was also necessary to report the extent to which the identified economic activities are taxonomy-aligned. According to the EU taxonomy, an economic activity qualifies as taxonomy-aligned if it is taxonomy-eligible and makes a substantial contribution to one of the environmental objectives without causing significant harm to the other objectives or failing to fulfill minimum social standards.
  • As well as the aforementioned information, the degree of taxonomy eligibility for economic activities making a substantial contribution to the following four additional environmental objectives of the EU were included in the disclosure obligation in the 2023 reporting year: 1) sustainable use and protection of water and marine resources, 2) transition to a circular economy, 3) pollution prevention and control, and 4) protection and restoration of biodiversity and ecosystems. Furthermore, new economic activities for the environmental objectives of climate change mitigation and climate change adaptation were added, for which the degree of taxonomy eligibility was required to be disclosed in the 2023 reporting year. Reporting on the degree of taxonomy alignment for these newly added environmental objectives was not required at this time.
  • From the 2024 reporting year, the degree of taxonomy eligibility and taxonomy alignment must be reported for all six environmental objectives.

Approach

To ensure the legally compliant fulfillment of its disclosure obligations, the Group has established an interdisciplinary project team that continuously analyzes the existence of taxonomy-eligible and taxonomy-aligned activities in close coordination with representatives of the business sectors and various Group functions.

Identification of taxonomy-eligible economic activities

When implementing the EU taxonomy requirements, the business model of the Group was subjected to a comprehensive analysis. Taxonomy-eligible economic activities were identified using a top-down approach on the basis of structured inquiries submitted to the relevant specialist departments. For the environmental objectives of climate change mitigation and climate change adaptation, the results of this analysis were supplemented by big data-supported analyses as part of a bottom-up approach. Among other things, the information referred to is also used in connection with the requirements of the REACH Regulation and in the context of customs declarations. The economic activities for the other four environmental objectives were also identified by referring to existing reporting structures and hierarchies.

As a result of this process, taxonomy-eligible activities generating net sales were identified only in conjunction with the following economic activities:

  • Manufacture of energy-efficient building equipment in the Electronics business sector (environmental objective “climate change mitigation”)
  • Manufacture of active pharmaceutical ingredients in the Healthcare and Life Science business sectors (environmental objective “pollution prevention and control”)
  • Manufacture of medical products in the Healthcare business sector (environmental objective “pollution prevention and control”)
  • Manufacture of electrical and electronic equipment in the Life Science business sector (environmental objective “transition to a circular economy”)

The EU Taxonomy Regulation differentiates between three categories of capital expenditure:

  • Capital expenditure that relates to assets or processes associated with taxonomy-aligned economic activities (category A)
  • Capital expenditure that is part of a plan to expand taxonomy-aligned economic activities or to transform taxonomy-eligible economic activities into taxonomy-aligned economic activities (category B)
  • Capital expenditure related to the acquisition of products from taxonomy-eligible economic activities and individual actions that enable the target activities to be performed in a low-carbon manner or that reduce greenhouse gas emissions (category C)

On account of its business model, the Group only engages in taxonomy-eligible economic activities in conjunction with the manufacture of active pharmaceutical ingredients, medical products, electrical and electronic equipment, and, to a limited extent, energy-efficient building equipment, meaning it has only limited taxonomy-eligible capital expenditure in category A. There is no capital expenditure in category B to date, as we are not preparing any plans for capital expenditure to transform taxonomy-eligible economic activities into taxonomy-aligned economic activities. Furthermore, the Group has capital expenditure resulting from the acquisition of products of taxonomy-eligible economic activities or attributable to qualifying individual actions (category C). In order to be taxonomy-eligible, this capital expenditure must correspond to one of the economic activities named in the Delegated Acts and must be implemented and operational within 18 months.

In the Group, such capital expenditure exists in connection with the environmental objective of climate change mitigation in particular and covers the following areas:

  • Electricity generation using solar photovoltaic technology (activity 4.1 of the Delegated Act on the “climate change mitigation” environmental objective)
  • Transport by motorbikes, passenger cars and light commercial vehicles (activity 6.5 of the Delegated Act on the “climate change mitigation” environmental objective)
  • In the previous year: renovation of existing buildings (activity 7.2 of the Delegated Act on the “climate change mitigation” environmental objective and activity 3.2 of the Delegated Act on the “circular economy” environmental objective)

Determination of taxonomy alignment

Technical screening criteria

In order to examine the taxonomy alignment of the taxonomy-eligible economic activities, a systematic analysis was conducted of the relevant regulations for the technical screening criteria, which are used to determine whether an economic activity contributes substantially to the environmental objective as well as whether the activity causes no significant harm to any of the other environmental objectives. This was based on the Delegated Acts on the EU taxonomy, which were used to identify taxonomy-eligible economic activities. They define corresponding requirements for the respective economic activities which must be fulfilled in order for them to be classified as taxonomy-aligned. For this purpose, interviews were conducted with business and project managers, and the physical climate risks at the sites were analyzed. Numerous documents were also inspected, including operating permits, product data sheets, environmental product declarations, energy performance certificates, and internal training documents.

Net sales, capital expenditure and operating expenditure in connection with the “climate change mitigation” environmental objective were only identified as taxonomy-aligned economic activities to a very small extent. No additional taxonomy-eligible and taxonomy-aligned net sales, capital expenditure or operating expenditure were identified for the “climate change adaptation” environmental objective. From 2024, the degree of taxonomy alignment must be reported for the other four environmental objectives in addition to the degree of taxonomy eligibility. Given the current state of the art, the taxonomy alignment of the activities identified by the Group as taxonomy-eligible cannot be guaranteed. This is due, in particular, to the stringent requirements profile of the technical screening criteria and the criteria for examining whether the activities cause significant harm to other environmental objectives set out in the catalog of the Taxonomy Regulation for the respective activities. With regard to the manufacture of active pharmaceutical ingredients and medical products in particular, the requirements concerning biodegradability and suitability for substitution with a similar active ingredient with the same efficacy cannot be met.

Minimum safeguards

The frameworks for determining minimum safeguards include the OECD Guidelines for Multinational Enterprises, the United Nations Guiding Principles on Business and Human Rights, the fundamental conventions of the International Labour Organization, and the International Bill of Human Rights. The requirements profile of the frameworks has been systematized and compared with internal documents, including an analysis of the Code of Conduct, work instructions, guidelines, and training documents. Compliance with the due diligence process required by the framework in the area of human rights is ensured with respect to the individual business activities. Risk analyses are carried out with regard to the minimum safeguard requirements and appropriate actions are derived from them.

Determination of the taxonomy KPIs

The three key performance indicators (KPIs), namely net sales, capital expenditure and operating expenditure, were derived mainly from existing financial reporting systems; the capital expenditure KPI was derived partly from, inquiries made to the Investment Controlling unit. The principle of materiality was applied.

Accounting and measurement policies

The EU Taxonomy Regulation and the corresponding Delegated Acts contain wording and requirements which are subject to interpretation, even taking into account the supplementary publications of the European Commission and the EU Platform on Sustainable Finance, and/or for which clarifications have not yet been published in every case. The most significant interpretive issues and the approach that  the Group is taking are presented below.

Taxonomy eligibility

Ancillary activities that are operationally necessary for our core business do not qualify as independent taxonomy-eligible economic activities. This applies, for example, to the transport of our products to our customers, research and development activities, and the acquisition or construction of production buildings in areas that cannot be allocated to a taxonomy-eligible target activity.

To examine the taxonomy eligibility of an economic activity, the Group applies an end product-oriented approach for manufacturing-related activities. This means the end product must result from one of the economic activities specified in the Delegated Act in order to qualify as being taxonomy-eligible. In the case of organic basic chemicals, the Group deems the corresponding economic activities taxonomy-eligible only if the manufacturing activities for the named chemical products involve a significant transformation process. In our interpretation, products that are merely passed on for sale, repackaged or mixed do not qualify as taxonomy-eligible within the meaning of the EU Taxonomy Regulation.

The purchase or performance of contract manufacturing services for active pharmaceutical ingredients or medical products in the Healthcare and Life Science business sectors typically does not give rise to a taxonomy-eligible economic activity, as the Group does not control the circumstances under which the contract manufacturing is performed in many cases.

In the area of fossil gas, the Group operates a gas turbine and a cogeneration facility at its Darmstadt site to generate electricity and heat from fossil gaseous fuels for its own use. These activities in the area of electricity generation from fossil gaseous fuels as well as the operation of cogeneration facilities with fossil gaseous fuels have been classified as not material. Additional activities in the field of nuclear energy and fossil gas are either not performed or are performed to an insignificant extent only.

Net sales

The net sales KPI represents the ratio of net sales from taxonomy-eligible or taxonomy-aligned economic activities in a fiscal year to the total net sales of the same fiscal year. The definition of relevant net sales for the purposes of the EU Taxonomy Regulation corresponds to the definition of net sales in the Consolidated Financial Statements (see Note (9) “Net sales” in the Notes to the Consolidated Financial Statements).

Capital expenditure

The share of capital expenditure for assets or processes associated with economic activities classified as taxonomy-eligible or taxonomy-aligned is determined as follows: The share of total capital expenditure that is taxonomy-eligible or taxonomy-aligned is divided by the total capital expenditure according to the EU Taxonomy Regulation. In the Group and within the meaning of the EU Taxonomy Regulation, capital expenditure in the reporting period comprises additions to property, plant and equipment (IAS 16), rights of use from leases (IFRS 16), and intangible assets (IAS 38) with the exception of goodwill. Apart from the additions, advance payments for the named assets are also included. The denominator also includes additions to property, plant and equipment and intangible assets resulting from business combinations. The additions can be seen in the statements of changes in property, plant and equipment and intangible assets published in the Consolidated Financial Statements (see Note (20) “Property, plant and equipment” and Note (19) “Other intangible assets” in the Notes to the Consolidated Financial Statements).

In order to systematically exclude double counting, capital expenditure on products from taxonomy-aligned economic activities and individual actions that have already been examined under category A (i.e. capital expenditure relating to assets or processes associated with taxonomy-aligned economic activities) is included under this category only. For example, this means that capital expenditure for production buildings is examined for taxonomy eligibility under category A only, while capital expenditure for administrative buildings is included under category C.

Operating expenditure

The share of operating expenditure for assets or processes associated with economic activities classified as taxonomy-eligible or taxonomy-aligned is determined as follows: The share of total operating expenditures that is taxonomy-eligible or taxonomy-aligned is divided by total operating expenditure according to the EU Taxonomy Regulation. Operating expenditure relevant within the scope of reporting under the EU Taxonomy Regulation includes direct, non-capitalized research and development costs, low-value leases, building renovations, maintenance and repair, and all other direct internal and external expenses related to the day-to-day maintenance of property, plant and equipment that are necessary to ensure the continuous and effective functioning of these assets. During the clinical and preclinical development phases in the Healthcare business sector, it is unclear as to whether the activities will ever lead to regulatory approval and hence to marketable products. Accordingly, the corresponding research and development activities are not included as taxonomy-eligible operating expenditure in the numerator for economic activities relating to pharmaceutical ingredients and medical products.

Taxonomy KPIs

The following tables present the share of net sales, capital expenditure (CapEx) and operating expenditure (OpEx) attributable to taxonomy-eligible and taxonomy-aligned economic activities.

Taxonomy KPIs – Turnover

 

 

 

 

 

 

 

 

Criteria for a substantial contribution

 

DNSH criteria (“Do no significant harm”)

 

 

 

 

 

 

 

 

Economic activities

 

Code

 

Turn­over
2024

 

Pro­por­tion of Turn­over
2024

 

Cli­mate change miti­gation

 

Cli­mate change adap­tation

 

Water

 

Pol­lution

 

Cir­cular eco­nomy

 

Bio­diver­sity

 

Cli­mate change miti­gation

 

Cli­mate change adap­tation

 

Water

 

Pol­lution

 

Cir­cular eco­nomy

 

Bio­diver­sity

 

Min­imum safe­guards

 

Propor­tion of Taxo­nomy-aligned or eli­gible turn­over 2023

 

Cate­gory en­abling acti­vity

 

Cate­gory transi­tional acti­v­ity

 

 

(a)

 

€ million

 

%

 

Y; N; N/EL (b)

 

Y; N; N/EL (b)

 

Y; N; N/EL (b)

 

Y; N; N/EL (b)

 

Y; N; N/EL (b)

 

Y; N; N/EL (b)

 

Y/N

 

Y/N

 

Y/N

 

Y/N

 

Y/N

 

Y/N

 

Y/N

 

%

 

E

 

T

A. TAXONOMY-ELIGIBLE ACTIVITIES

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

A.1. Environmentally sustainable activities (taxonomy-aligned)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Manufacture of energy efficiency equipment for buildings (A1)

 

CCM 3.5

 

1

 

0.01

 

Y

 

N/EL

 

N/EL

 

N/EL

 

N/EL

 

N/EL

 

 

 

Y

 

Y

 

Y

 

Y

 

Y

 

Y

 

0.03

 

E

 

 

Turnover of environmentally sustainable activities (taxonomy-aligned) (A.1)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Of which enabling

 

 

 

1

 

0.01

 

0.01

 

0.00

 

0.00

 

0.00

 

0.00

 

0.00

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

0.03

 

E

 

 

Of which transitional

 

 

 

0.00

 

0.00

 

0.00

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

0.00

 

 

 

T

A.2 Taxonomy-eligible, but not environmentally sustainable activities (not taxonomy-aligned activities)

 

 

 

 

 

 

 

EL; N/EL

 

EL; N/EL

 

EL; N/EL

 

EL; N/EL

 

EL; N/EL

 

EL; N/EL

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Manufacture of active pharmaceutical ingredients (API) or active substances

 

PPC 1.1

 

125

 

0.59

 

N/EL

 

N/EL

 

N/EL

 

EL

 

N/EL

 

N/EL

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

0.47

 

 

 

 

Manufacture of medicinal products

 

PPC 1.2

 

6,011

 

28.41

 

N/EL

 

N/EL

 

N/EL

 

EL

 

N/EL

 

N/EL

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

27.52

 

 

 

 

Manufacture of electrical and electronic equipment

 

CE 1.2

 

99

 

0.47

 

N/EL

 

N/EL

 

N/EL

 

N/EL

 

EL

 

N/EL

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

0.47

 

 

 

 

Turnover of taxonomy-eligible but not environmentally sustainable activities (not taxonomy-aligned activities) (A.2)

 

 

 

6,236

 

29.48

 

0.00

 

0.00

 

0.00

 

29.01

 

0.47

 

0.00

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

28.46

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

A. Turnover of taxonomy eligible activities
(A.1 + A.2)

 

 

 

6,237

 

29.48

 

0.01

 

0.00

 

0.00

 

29.01

 

0.47

 

0.00

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

B. TAXONOMY-NON-ELIGIBLE ACTIVITIES

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Turnover of taxonomy-non-eligible activities (B)

 

 

 

14,919

 

70.52

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total (A + B)

 

 

 

21,156

 

100.00

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Taxonomy KPIs – CapEx

 

 

 

 

 

 

 

 

Criteria for a substantial contribution

 

DNSH criteria (“Do no significant harm”)

 

 

 

 

 

 

 

 

Economic activities

 

Code

 

CapEx 2024

 

Pro­por­tion of CapEx 2024

 

Cli­mate change miti­gation

 

Cli­mate change adap­tation

 

Water

 

Pol­lution

 

Cir­cular eco­nomy

 

Bio­diver­sity

 

Cli­mate change miti­gation

 

Cli­mate change adap­tation

 

Water

 

Pol­lution

 

Cir­cular eco­nomy

 

Bio­diver­sity

 

Min­imum safe­guards

 

Pro­por­tion of Taxo­nomy aligned or eligible CapEx 2023

 

Cate­gory en­abling acti­vity

 

Cate­gory transi­tional acti­vity

 

 

(a)

 

€ million

 

%

 

Y; N; N/EL (b)

 

Y; N; N/EL (b)

 

Y; N; N/EL (b)

 

Y; N; N/EL (b)

 

Y; N; N/EL (b)

 

Y; N; N/EL (b)

 

Y/N

 

Y/N

 

Y/N

 

Y/N

 

Y/N

 

Y/N

 

Y/N

 

%

 

E

 

T

A. TAXONOMY-ELIGIBLE ACTIVITIES

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

A.1 Environemtally sustainable activities (taxonomy-aligned)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Manufacture of energy efficiency equipment for buildings

 

CCM 3.5

 

1

 

0.02

 

Y

 

N/EL

 

N/EL

 

N/EL

 

N/EL

 

N/EL

 

 

 

Y

 

Y

 

Y

 

Y

 

Y

 

Y

 

0.06

 

E

 

 

Electricity generation using solar photovoltaic technology

 

CCM 4.1

 

1

 

0.04

 

Y

 

N/EL

 

N/EL

 

N/EL

 

N/EL

 

N/EL

 

 

 

Y

 

Y

 

Y

 

Y

 

Y

 

Y

 

0.17

 

E

 

 

Renovation of existing buildings

 

CCM 7.2

 

0

 

0.00

 

Y

 

N/EL

 

N/EL

 

N/EL

 

N

 

N/EL

 

 

 

Y

 

Y

 

Y

 

Y

 

Y

 

Y

 

0.43

 

 

 

T

CapEx of environmentally sustainable activities (taxonomy aligned) (A.1)

 

 

 

2

 

0.07

 

0.07

 

0.00

 

0.00

 

0.00

 

0.00

 

0.00

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

0.66

 

 

 

 

Of which enabling

 

 

 

2

 

0.07

 

0.07

 

0.00

 

0.00

 

0.00

 

0.00

 

0.00

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

E

 

 

Of which transitional

 

 

 

0

 

0.00

 

0.00

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

T

A.2 Taxonomy-eligible, but not environmentally sustainable activities (not taxonomy-aligned activities)

 

 

 

 

 

 

 

EL; N/EL

 

EL; N/EL

 

EL; N/EL

 

EL; N/EL

 

EL; N/EL

 

EL; N/EL

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Transport by motorbikes, passenger cars and light commercial vehicles (A.2)

 

CCM 6.5

 

28

 

1.22

 

EL

 

N/EL

 

N/EL

 

N/EL

 

N/EL

 

N/EL

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1,35

 

 

 

 

Manufacture of active pharmaceutical ingredients (API) or active substances

 

PPC 1.1

 

1

 

0.05

 

N/EL

 

N/EL

 

N/EL

 

EL

 

N/EL

 

N/EL

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

0.04

 

 

 

 

Manufacture of medicinal products

 

PPC 1.2

 

81

 

3.47

 

N/EL

 

N/EL

 

N/EL

 

EL

 

N/EL

 

N/EL

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

4.27

 

 

 

 

CapEx of taxonomy-eligible but not environmentally sustainable activities (not taxonomy-aligned activities) (A.2)

 

 

 

111

 

4.73

 

1.22

 

0.00

 

0.00

 

3.52

 

0.00

 

0.00

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

5.67

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

A. CapEx of taxonomy eligible activities
(A.1 + A.2)

 

 

 

112

 

4.80

 

1.28

 

0.00

 

0.00

 

3.52

 

0.00

 

0.00

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

B. TAXONOMY-NON-ELIGIBLE ACTIVITIES

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

CapEx of taxonomy-non-eligible activities (B)

 

 

 

2,229

 

95.20

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total (A + B)

 

 

 

2,341

 

100.00

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Taxonomy KPIs – OpEx

 

 

 

 

 

 

 

 

Criteria for a substantial contribution

 

DNSH criteria (“Do no significant harm”)

 

 

 

 

 

 

 

 

Economic activities

 

Code

 

OpEx 2024

 

Propor­tion of OpEx 2024

 

Cli­mate change miti­gation

 

Cli­mate change adap­tation

 

Water

 

Pol­lution

 

Cir­cular eco­nomy

 

Bio­diver­sity

 

Cli­mate change miti­gation

 

Cli­mate change adap­tation

 

Water

 

Pol­lution

 

Cir­cular eco­nomy

 

Bio­diver­sity

 

Min­imum safe­guards

 

Pro­por­tion of Taxo­nomy aligned or eligible OpEx 2023

 

Cate­gory en­abling acti­v­ity

 

Cate­gory transi­tional acti­vity

 

 

(a)

 

€ million

 

%

 

Y; N; N/EL (b)

 

Y; N; N/EL (b)

 

Y; N; N/EL (b)

 

Y; N; N/EL (b)

 

Y; N; N/EL (b)

 

Y; N; N/EL (b)

 

Y / N

 

Y / N

 

Y / N

 

Y / N

 

Y / N

 

Y / N

 

Y / N

 

%

 

E

 

T

A. TAXONOMY-ELIGIBLE ACTIVITIES

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

A.1 Environemtally sustainable activities (taxonomy-aligned)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Manufacture of energy efficiency equipment for buildings

 

CCM 3.5

 

1

 

0.02

 

Y

 

N/EL

 

N/EL

 

N/EL

 

N/EL

 

N/EL

 

 

 

Y

 

Y

 

Y

 

Y

 

Y

 

Y

 

0.02

 

E

 

 

OpEx of environmentally sustainable activities (taxonomy aligned) (A.1)

 

 

 

1

 

0.02

 

0.02

 

0.00

 

0.00

 

0.00

 

0.00

 

0.00

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

0.02

 

 

 

 

Of which enabling

 

 

 

1

 

0.02

 

0.02

 

0.00

 

0.00

 

0.00

 

0.00

 

0.00

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

0.02

 

E

 

 

Of which transitional

 

 

 

0.00

 

0.00

 

0.00

 

0.00

 

0.00

 

0.00

 

0.00

 

0.00

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

0.00

 

 

 

T

A.2 Taxonomy-eligible, but not environmentally sustainable activities (not taxonomy-aligned activities)

 

 

 

 

 

 

 

EL; N/EL

 

EL; N/EL

 

EL; N/EL

 

EL; N/EL

 

EL; N/EL

 

EL; N/EL

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Renovation of existing buildings (A.1)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Manufacture of active pharmaceutical ingredients (API) or active substances

 

PPC 1.1

 

1

 

0.05

 

N/EL

 

N/EL

 

N/EL

 

EL

 

N/EL

 

N/EL

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

0.11

 

 

 

 

Manufacture of medicinal products

 

PPC 1.2

 

32

 

1.24

 

N/EL

 

N/EL

 

N/EL

 

EL

 

N/EL

 

N/EL

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1.73

 

 

 

 

Manufacture of electrical and electronic equipment

 

CE 1.2

 

1

 

0.04

 

N/EL

 

N/EL

 

N/EL

 

N/EL

 

EL

 

N/EL

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

0.16

 

 

 

 

OpEx of taxonomy-eligible but not environmentally sustainable activities (not taxonomy-aligned activities) (A.2)

 

 

 

34

 

1.33

 

0.00

 

0.00

 

0.00

 

1.29

 

0.04

 

0.00

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1.99

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

A. OpEx of taxonomy eligible activities
(A.1 + A.2)

 

 

 

35

 

1.35

 

0.02

 

0.00

 

0.00

 

1.29

 

0.04

 

0.00

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

B. TAXONOMY-NON-ELIGIBLE ACTIVITIES

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

OpEx of taxonomy-non-eligible activities (B)

 

 

 

2,556

 

98.65

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total (A + B)

 

 

 

2,591

 

100.00

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(a) The code is the abbreviation of the relevant objective to which the economic activity can make a substantial contribution, as well as the section number of the activity in the relevant Annex covering the objective, i.e.

Climate change mitigation: CCM
Climate change adaptation: CCA
Water and marine resources: WTR
Circular economy: CE
Pollution prevention and control: PPC
Biodiversity and ecosystems: BIO

(b) Y — Yes, activity is taxonomy-eligible and is taxonomy-aligned with the relevant environmental objective
N — No, activity is taxonomy-eligible but not taxonomy-aligned with the relevant environmental objective
N/EL — Activity is not taxonomy-eligible for the relevant environmental objective

Research and development expenses accounted for € 2,279 million (2023: € 2,445 million) of the presented operating expenditure, with € 1,503 million (2023: € 1,657 million) being attributable to the Healthcare business sector.

Share this page: